equol has been researched along with Osteoporosis, Postmenopausal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Cui, H; Li, S; Ni, X; Wang, J; Wu, B; Xu, Z; Zhang, G; Zhu, W | 1 |
| Cannavo, A; Conti, V; Corbi, G; Davinelli, S; Medoro, A; Nobile, V; Scapagnini, G; Sorrenti, V | 1 |
| Abe, F; Ishimi, Y; Kimira, Y; Tousen, Y; Uehara, M | 1 |
| Chua, WH; Ishimi, Y; Kruger, MC; Tadaishi, M; Tousen, Y; Wolber, FM | 1 |
| Barnes, S; Jackson, GS; Martin, BR; McCabe, GP; McCabe, L; Pawlowski, JW; Peacock, M; Weaver, CM | 1 |
| Kruger, MC; Loots, du T; Moughan, PJ; Poulsen, RC | 1 |
| Ishimi, Y | 1 |
| Frankenfeld, CL; Holt, VL; LaCroix, K; Lampe, JW; McTiernan, A; McVarish, L; Schwartz, SM; Thomas, WK | 1 |
| Chilibeck, PD; Vatanparast, H | 1 |
| Brüggemann-Rotgans, IE; Kardinaal, AF; Morton, MS; van Beresteijn, EC | 1 |
| Kinjo, J | 1 |
3 review(s) available for equol and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
[Nutrition and bone health. Isoflavones in bone health].
Topics: Animals; Bone and Bones; Bone Density; Equol; Exercise; Female; Humans; Individuality; Intestinal Mucosa; Isoflavones; Menopause; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic | 2009 |
Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype?
Topics: Bone Density; Equol; Female; Gastrointestinal Tract; Genistein; Glycine max; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phenotype; Phytoestrogens; Postmenopause | 2007 |
[Phytoestrogens].
Topics: Bacteria; Chromans; Digestive System; Equol; Estrogens, Non-Steroidal; Female; Gene Expression; Genistein; Humans; Isoflavones; Myocardial Ischemia; Neoplasms; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Receptors, Estrogen | 2000 |
3 trial(s) available for equol and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Bone Remodeling; Equol; Female; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Resveratrol; Tartrate-Resistant Acid Phosphatase | 2023 |
Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
Topics: beta-Glucans; Biomarkers; Cross-Over Studies; Dietary Supplements; Equol; Female; Glycine max; Humans; Intestinal Mucosa; Intestines; Isoflavones; Japan; Middle Aged; Oligosaccharides; Osteoporosis, Postmenopausal; Pilot Projects; Postmenopause; Prebiotics; Seeds | 2013 |
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Topics: Administration, Oral; Aged; Bone and Bones; Calcium; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Equol; Female; Genistein; Glycine max; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Postmenopause; Risedronic Acid | 2015 |
6 other study(ies) available for equol and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Equol exerts a protective effect on postmenopausal osteoporosis by upregulating OPG/RANKL pathway.
Topics: Animals; Equol; Estrogen Receptor beta; Female; Humans; Osteoblasts; Osteoporosis, Postmenopausal; Osteoprotegerin; Phytoestrogens; RANK Ligand; Rats | 2023 |
Effects of daidzein and kiwifruit on bone mineral density and equol production in ovariectomised rats.
Topics: Actinidia; Animals; Bone Density; Cecum; Dietary Supplements; Drug Synergism; Equol; Female; Fruit; Humans; Isoflavones; Osteoporosis, Postmenopausal; Ovariectomy; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley | 2014 |
Ileal and faecal digestibility of daidzein and genistein and plasma bioavailability of these isoflavones and their bioactive metabolites in the ovariectomised rat.
Topics: Animals; Bacteria; Biological Availability; Digestion; Disease Models, Animal; Equol; Feces; Female; Genistein; Humans; Ileum; Isoflavones; Osteoporosis, Postmenopausal; Ovariectomy; Phenols; Rats; Rats, Sprague-Dawley | 2009 |
The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
Topics: Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Dietary Supplements; Endometrial Neoplasms; Equol; Female; Glycine max; Humans; Isoflavones; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Risk Assessment; Soybean Proteins; Treatment Outcome; Women's Health | 2011 |
Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Equol; Female; Humans; Intestines; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phenotype; Phytoestrogens; Postmenopause; Soybean Proteins | 2006 |
Phyto-oestrogen excretion and rate of bone loss in postmenopausal women.
Topics: 4-Butyrolactone; Aging; Bone Density; Chromans; Equol; Estrogens, Non-Steroidal; Female; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Lignans; Linear Models; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Postmenopause; Prospective Studies; Time Factors | 1998 |